Abstract: An embodiment electrolyte solution includes a lithium salt, a solvent, and a functional additive, wherein the functional additive includes 4-((tert-butoxydimethylsilyl)methyl)-5-methyl-1,3-dioxol-2-one represented by as an electrode film additive. An embodiment lithium secondary battery includes the above-described electrolyte solution, a positive electrode including a positive electrode active material including Ni, Co, and Mn, a negative electrode including a carbon-based negative electrode active material or a silicon-based negative electrode active material, and a separator interposed between the positive electrode and the negative electrode.

Abstract: An embodiment electrolyte solution includes a lithium salt, a solvent, and a functional additive, wherein the functional additive includes an electrode film additive of 2-(dodec-1-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane represented by An embodiment lithium secondary battery includes this electrolyte solution, a positive electrode including a positive-electrode active material including Ni, Co, and Mn, a negative electrode including a negative-electrode active material including a carbon (C)-based material or a silicon (Si)-based material, and a separator interposed between the positive electrode and the negative electrode.

Abstract: The present disclosure relates to an electrolyte solution for a lithium secondary battery capable of improving the output and lifespan characteristics at high temperature of a lithium secondary battery, and a lithium secondary battery including the same. An electrolyte solution for a lithium secondary battery includes a lithium salt, a solvent, and a functional additive, wherein the functional additive includes a first negative-electrode film additive, which is silver p-toluenesulfonate.

Abstract: Disclosed are an electrolyte solution for a lithium secondary battery capable of improving the output and lifespan characteristics at high temperature of a lithium secondary battery, and a lithium secondary battery including the same. The electrolyte solution includes a lithium salt, a solvent, and a functional additive. The functional additive includes benzo[d]thiazol-6-yl(fluorosulfonyl)sulfamoyl fluoride.

Abstract: The present disclosure relates to an electrolyte solution for a lithium secondary battery capable of improving the output and lifespan characteristics at high temperature of a lithium secondary battery, and a lithium secondary battery including the same. An electrolyte solution for a lithium secondary battery includes a lithium salt, a solvent, and a functional additive, wherein the functional additive includes a positive-electrode film additive, which is 3-(4-cyano-5-(4-nitrophenyl)-1H-1,2,3-triazol-1-yl)propyl methanesulfonate.

Abstract: The present disclosure relates to an electrolyte solution for a lithium secondary battery capable of improving the output and lifespan characteristics at high temperature of a lithium secondary battery, and a lithium secondary battery including the same. An electrolyte solution for a lithium secondary battery includes a lithium salt, a solvent, and a functional additive, wherein the functional additive includes a first electrode film additive, which is 3-(4-cyano-5-(4-nitrophenyl)-1H-1,2,3-triazol-1-yl)propyl 4-methylbenzenesulfonate.

Abstract: Disclosed are an electrolyte solution for a lithium secondary battery capable of improving the output and lifespan characteristics at high temperature of a lithium secondary battery, and a lithium secondary battery including the same. An electrolyte solution for a lithium secondary battery includes a lithium salt, a solvent, and a functional additive, and in particular, the functional additive includes (4-(1H-1,2,4-triazol-1-yl)phenyl)(fluorosulfonyl)sulfamoyl fluoride.

Abstract: The present disclosure relates to an electrolyte solution for a lithium secondary battery capable of improving the output and lifespan characteristics at high temperature of a lithium secondary battery, and a lithium secondary battery including the same. An electrolyte solution for a lithium secondary battery includes a lithium salt, a solvent, and a functional additive, wherein the functional additive includes a negative-electrode film additive, which is silver p-toluenesulfonate.

Abstract: A core-shell copolymer, a method of making the same, and a thermoplastic resin composition including the same are disclosed herein. In some embodiments, a core-shell copolymer includes a core and a shell surrounding the core, the core includes a conjugated diene-based monomer-derived repeating unit and a phosphate-based cross-linking agent-derived cross-linking part represented by Formula 1, and the shell includes a first alkyl (meth)acrylate monomer-derived repeating unit, a second alkyl (meth)acrylate monomer-derived repeating unit, and a sulfonate-based ionic monomer-derived repeating unit represented by Formula 2. The core is 68 parts to 92 parts and the shell is 8 parts to 32 parts, based on 100 parts of the core-shell copolymer, the core has a swell index of 2.7 to 10.9, the shell includes 1 wt % to 16 wt % of the sulfonate-based ionic monomer-derived repeating unit, and the shell has a weight average molecular weight of 105,000 g/mol to 645,000 g/mol.

Abstract: The present invention relates to an applicator apparatus for dyeing and finishing in which diagonal application grooves are formed in a longitudinal direction in an outer circumferential surface of a roller used to apply a chemical and reverse diagonal application grooves are formed to intersect the formed diagonal application grooves to allow the chemical to be evenly discharged to an outer circumferential surface of a pickup roller so that fabric dyeing efficiency is increased.

Abstract: Provided is a technique for deriving a mathematical function for defining arterial and venous blood flow in the body by using a four-dimensional medical image. A method of analyzing blood flow by using a medical image according to an embodiment of the present disclosure includes: determining a position of a blood vessel from four-dimensional medical image data that is obtained by combining data of three-dimensional medical images of a patient's body captured at a preset period; deriving a primary function for an arterial input function and a venous output function by using a vascular signal in a head region and a vascular signal in a heart region from among vascular signals included in three-dimensional medical image data for the position of the blood vessel determined in the determining; and deriving a secondary function that is a final function for the arterial input function and the venous output function by using the primary function and a vascular signal in a neck region.

Abstract: Provided is a technique for deriving a mathematical function for defining arterial and venous blood flow in the body by using a four-dimensional medical image. A method of analyzing blood flow by using a medical image according to an embodiment of the present disclosure includes: determining a position of a blood vessel from four-dimensional medical image data that is obtained by combining data of three-dimensional medical images of a patient's body captured at a preset period; deriving a primary function for an arterial input function and a venous output function by using a vascular signal in a head region and a vascular signal in a heart region from among vascular signals included in three-dimensional medical image data for the position of the blood vessel determined in the determining; and deriving a secondary function that is a final function for the arterial input function and the venous output function by using the primary function and a vascular signal in a neck region.

Abstract: A method of removing distortion by lipids from an MR image includes obtaining an MR image including voxels, obtaining data of the voxels from the obtained MR image, estimating a lipid-related spectrum by using the obtained data, and removing the estimated lipid-related spectrum from the obtained data.

Abstract: A method obtains a magnetic resonance (MR) spectrum of a voxel in a magnetic resonance (MR) image obtained from a magnetic resonance imaging (MRI) apparatus. The method includes configuring a sampling pattern of k-space data; sampling predetermined data from the k-space data based on the configured sampling pattern; and obtaining the MR spectrum of the voxel by using the sampled data.

Abstract: A method obtains a magnetic resonance (MR) spectrum of a voxel in a magnetic resonance (MR) image obtained from a magnetic resonance imaging (MRI) apparatus. The method includes configuring a sampling pattern of k-space data; sampling predetermined data from the k-space data based on the configured sampling pattern; and obtaining the MR spectrum of the voxel by using the sampled data.

Abstract: A method of removing distortion by lipids from an MR image includes obtaining an MR image including voxels, obtaining data of the voxels from the obtained MR image, estimating a lipid-related spectrum by using the obtained data, and removing the estimated lipid-related spectrum from the obtained data.